Insider Monkey
Citi Reduces PT on GE HealthCare Technologies (GEHC) Stock
📊
AI Sentiment
Positive
6/10
- Home
- GEHC
as of 03-23-2026 3:36pm EST
$72.09
+$2.41
+3.47%
GE HealthCare Technologies is a leading medical technology firm with leading market share in imaging and ultrasound equipment. The company reports four major segments: imaging (45% of revenue), advanced visualization solutions (26%), patient care solutions (16%), and pharmaceutical diagnostics (13%). The company's sales are geographically diverse, with the United States, EMEA, China, and the rest of the world accounting for 46%, 26%, 12%, and 17% respectively. We estimate approximately half of its revenue is recurring, which consists of servicing (about one third of revenue), pharmaceutical diagnostics (about 10%-15%), and digital solutions (just over 5%).
| Founded: | 1892 | Country: | United States |
| Employees: | N/A | City: | CHICAGO |
| Market Cap: | 35.8B | IPO Year: | 2022 |
| Target Price: | $90.83 | AVG Volume (30 days): | 2.9M |
| Analyst Decision: | Buy | Number of Analysts: | 12 |
| Dividend Yield: | Dividend Payout Frequency: | quarterly | |
| EPS: | 4.55 | EPS Growth: | 4.84 |
| 52 Week Low/High: | $57.65 - $89.77 | Next Earning Date: | 04-29-2026 |
| Revenue: | $20,625,000,000 | Revenue Growth: | 4.84% |
| Revenue Growth (this year): | 7.06% | Revenue Growth (next year): | 4.50% |
| P/E Ratio: | 15.31 | Index: | |
| Free Cash Flow: | N/A | FCF Growth: | -2.90% |
AI-Powered GEHC Daily Prediction
Machine learning model trained on 25+ technical indicators
Updated a day ago
AI Recommendation
hold
Model Accuracy: 76.09%
76.09%
Confidence
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
Earnings Transcripts
SEC 8-K filings with transcript text
2025 Q4 Q4 2025 Earnings
8-K SELL Feb 4, 2026 · 100% conf.
2025
Q4
Q4 2025 Earnings
8-K SELLFeb 4, 2026 · 100% conf.
AI Prediction SELL
1D
-1.81%
$81.09
Act: -0.28%
5D
-2.62%
$80.42
Act: -4.10%
20D
-2.18%
$80.78
Price: $82.58 Prob +5D: 0% AUC: 1.000
0001932393-26-000006
gehc-202602040001932393false00019323932026-02-042026-02-04
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) February 4, 2026
GE HEALTHCARE TECHNOLOGIES INC.
(Exact name of registrant as specified in its charter)
Delaware001-4152888-2515116 (State or other jurisdiction of incorporation)(Commission File Number)(IRS Employer Identification No.)
500 W. Monroe Street, Chicago, IL 60661 (Address of principal executive offices) (Zip Code)
(Registrant’s telephone number, including area code) (833) 735-1139
(Former name or former address, if changed since last report.)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each class Trading Symbol(s) Name of each exchange on which registered
Common stock, par value $0.01 per share
GEHC
The Nasdaq Stock Market LLC
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 or Rule 12b-2 of the Securities Exchange Act of 1934. Emerging growth company☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards pursuant to Section 13(a) of the Exchange Act.☐
Item 2.02 Results of Operations and Financial Condition.
On February 4, 2026, GE HealthCare Technologies Inc. (“GE HealthCare”) issued a press release announcing its fourth quarter 2025 and fiscal year ended December 31, 2025 financial results. A copy of this press release is furnished as Exhibit 99 to this Current Report on Form 8-K.
The information furnished pursuant to Item 2.02, including Exhibit 99, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities under that Section and shall not be deemed to be incorporated by reference into any filing of GE HealthCare under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such filing.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits
ExhibitDescription 99 Press release of GE HealthCare Technologies Inc., dated February 4, 2026.
104The cover page of this Current Report on Form 8-K, formatted in Inline XBRL.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
GE HealthCare Technologies Inc. (Registrant)
Date: February 4, 2026 /s/ George A. Newcomb George A. Newcomb, Controller & Chief Accounting Officer (authorized signatory)
2025 Q3 Q3 2025 Earnings
8-K Oct 29, 2025
2025
Q3
Q3 2025 Earnings
8-KOct 29, 2025
0001932393-25-000052
gehc-202510290001932393false00019323932025-10-292025-10-29
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) October 29, 2025
GE HEALTHCARE TECHNOLOGIES INC.
(Exact name of registrant as specified in its charter)
Delaware001-4152888-2515116 (State or other jurisdiction of incorporation)(Commission File Number)(IRS Employer Identification No.)
500 W. Monroe Street, Chicago, IL 60661 (Address of principal executive offices) (Zip Code)
(Registrant’s telephone number, including area code) (833) 735-1139
(Former name or former address, if changed since last report.)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each class Trading Symbol(s) Name of each exchange on which registered
Common stock, par value $0.01 per share
GEHC
The Nasdaq Stock Market LLC
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 or Rule 12b-2 of the Securities Exchange Act of 1934. Emerging growth company☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards pursuant to Section 13(a) of the Exchange Act.☐
Item 2.02 Results of Operations and Financial Condition.
On October 29, 2025, GE HealthCare Technologies Inc. (“GE HealthCare”) issued a press release announcing its third quarter 2025 financial results. A copy of this press release is furnished as Exhibit 99 to this Current Report on Form 8-K.
The information furnished pursuant to Item 2.02, including Exhibit 99, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities under that Section and shall not be deemed to be incorporated by reference into any filing of GE HealthCare under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such filing.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits
ExhibitDescription 99 Press release of GE HealthCare Technologies Inc., dated October 29, 2025.
104The cover page of this Current Report on Form 8-K, formatted in Inline XBRL.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
GE HealthCare Technologies Inc. (Registrant)
Date: October 29, 2025 /s/ George A. Newcomb George A. Newcomb, Controller & Chief Accounting Officer (authorized signatory)
2025 Q2 Q2 2025 Earnings
8-K Jul 30, 2025
2025
Q2
Q2 2025 Earnings
8-KJul 30, 2025
0001932393-25-000048
gehc-202507300001932393false00019323932025-07-302025-07-30
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) July 30, 2025
GE HEALTHCARE TECHNOLOGIES INC.
(Exact name of registrant as specified in its charter)
Delaware001-4152888-2515116 (State or other jurisdiction of incorporation)(Commission File Number)(IRS Employer Identification No.)
500 W. Monroe Street, Chicago, IL 60661 (Address of principal executive offices) (Zip Code)
(Registrant’s telephone number, including area code) (833) 735-1139
(Former name or former address, if changed since last report.)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instructions A.2. below):
☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each class Trading Symbol(s) Name of each exchange on which registered
Common stock, par value $0.01 per share
GEHC
The Nasdaq Stock Market LLC
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter). Emerging growth company☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards pursuant to Section 13(a) of the Exchange Act.☐
Item 2.02 Results of Operations and Financial Condition.
On July 30, 2025, GE HealthCare Technologies Inc. (“GE HealthCare”) issued a press release announcing its second quarter 2025 financial results. A copy of this press release is furnished as Exhibit 99 to this Current Report on Form 8-K.
The information furnished pursuant to Item 2.02, including Exhibit 99, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities under that Section and shall not be deemed to be incorporated by reference into any filing of GE HealthCare under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such filing.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits
ExhibitDescription 99 Press release of GE HealthCare Technologies Inc., dated July 30, 2025.
104The cover page of this Current Report on Form 8-K, formatted in Inline XBRL.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
GE HealthCare Technologies Inc. (Registrant)
Date: July 30, 2025 /s/ George A. Newcomb George A. Newcomb, Controller & Chief Accounting Officer (authorized signatory)
Latest GE HealthCare Technologies Inc. News
GEHC Breaking Stock News: Dive into GEHC Ticker-Specific Updates for Smart Investing
Zacks
GEHC Acquires Intelerad to Boost Cloud-First, AI Imaging Capabilities
📈
AI Sentiment
Highly Positive
9/10
Simply Wall St.
Stryker Investors Weigh Cyberattack Recovery As CEO Joins GE HealthCare Board
📊
AI Sentiment
Positive
7/10
Zacks
Hologic's Women's Health Index Flags Alarming Gaps in STI Screening
➖
AI Sentiment
Neutral
4/10
Business Wire
GE HealthCare completes Intelerad acquisition – accelerating shift to cloud-first enterprise solutions to deliver precision care
📈
AI Sentiment
Highly Positive
9/10
Zacks
Should You Hold or Sell HOLX Stock as It Nears the End of Public Phase?
➖
AI Sentiment
Neutral
4/10
Business Wire
GE HealthCare appoints medtech leader Kevin Lobo to Board of Directors
📈
AI Sentiment
Highly Positive
8/10
Compare GEHC vs Leading Stocks
See how GEHC stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "GEHC GE HealthCare Technologies Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.